Published in Eur J Biochem on November 15, 1978
Studies on the intracellular segregation of polyribosome-associated messenger ribonucleic acid species in the lactating guinea-pig mammary gland. Biochem J (1979) 1.19
Isolation and characterisation of genes for androgen-responsive secretory proteins of rat seminal vesicles. Nucleic Acids Res (1983) 1.07
Abundant androgen regulated mRNAs in mouse submandibular gland: cell-free translation of renin precursor mRNA. Nucleic Acids Res (1981) 0.93
Androgenic regulation of messenger RNA in rat epididymis. Biochem J (1980) 0.92
Isolation and partial purification of the major abundant class rat seminal vesicle poly(A+)-messenger RNA. Nucleic Acids Res (1979) 0.90
The construction, identification and characterisation of plasmids containing human alpha-lactalbumin cDNA sequences. Nucleic Acids Res (1981) 0.89
A microcomputer program for analysis of nucleic acid hybridization data. Nucleic Acids Res (1982) 0.86
Developmental regulation of secretory protein synthesis in rat seminal vesicle. Proc Natl Acad Sci U S A (1981) 0.85
Isolation and characterisation of genomic and cDNA clones for an androgen-regulated secretory protein of rat seminal vesicles. Nucleic Acids Res (1983) 0.82
Regulation of protein synthesis in rat ventral prostate: cell-free translation of mRNA. Proc Natl Acad Sci U S A (1979) 0.80
Characterization of hormonally regulated secretory proteins from the caput epididymidis of the rabbit. Biochem J (1981) 0.79
A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature (1997) 11.15
A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res (1995) 7.95
Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol (1997) 4.71
Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J (1992) 4.69
Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J (1995) 4.23
Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology (1994) 4.10
The endocrinology and developmental biology of the prostate. Endocr Rev (1987) 3.58
A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect (1995) 3.47
Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell (1990) 3.37
Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci U S A (1994) 3.10
HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene (1995) 2.84
Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res (1989) 2.70
Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol (1994) 2.62
Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor. EMBO J (1998) 2.44
Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem (1997) 2.39
Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol Endocrinol (1993) 2.37
The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci (1993) 2.04
Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc Natl Acad Sci U S A (1990) 2.03
17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene (1996) 2.01
The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol Cell Biol (1999) 2.00
Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci U S A (1992) 1.96
The estrogenic activity of phthalate esters in vitro. Environ Health Perspect (1997) 1.94
Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein. Mol Cell Biol (1995) 1.77
Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice. Infect Immun (1984) 1.75
Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol (1993) 1.72
The activities of fructose diphosphatase in flight muscles from the bumble-bee and the role of this enzyme in heat generation. Biochem J (1972) 1.69
Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium. Proc Natl Acad Sci U S A (1987) 1.64
Reduction mammaplasty: an outcome analysis. Ann Plast Surg (1995) 1.62
Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. J Mol Endocrinol (2001) 1.59
Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors. J Biol Chem (2000) 1.59
A consensus DNA-binding site for the androgen receptor. Mol Endocrinol (1992) 1.59
AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Mol Cell Biol (1997) 1.58
Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta. J Biol Chem (2000) 1.54
The active site and mechanism of action of bovine pancreatic ribonuclease. 7. The catalytic mechanism. Biochem J (1962) 1.47
The activities of pyruvate carboxylase, phosphoenolpyruvate carboxylase and fructose diphosphatase in muscles from vertebrates and invertebrates. Biochem J (1972) 1.46
Molecular determinants of the estrogen receptor-coactivator interface. Mol Cell Biol (1999) 1.46
Some kinetic properties of human-milk galactosyl transferase. Eur J Biochem (1974) 1.39
RIP-140 interacts with multiple nuclear receptors by means of two distinct sites. Mol Cell Biol (1996) 1.39
Regulation of gene expression by nuclear hormone receptors. Curr Opin Cell Biol (1989) 1.37
Rat prostatic steroid binding protein: DNA sequence and transcript maps of the two C3 genes. EMBO J (1983) 1.35
Androgen-dependent synthesis of basic secretory proteins by the rat seminal vesicle. Biochem J (1976) 1.35
An outcomes analysis and satisfaction survey of 199 consecutive abdominoplasties. Ann Plast Surg (2001) 1.33
A comparison of transcriptional activation by ER alpha and ER beta. J Steroid Biochem Mol Biol (1999) 1.31
Steroid-induced nuclear binding of glucocorticoid receptors in intact hepatoma cells. J Mol Biol (1973) 1.29
Core LXXLL motif sequences in CREB-binding protein, SRC1, and RIP140 define affinity and selectivity for steroid and retinoid receptors. J Biol Chem (2000) 1.29
Molecular mechanisms of steroid hormone action. Adv Cancer Res (1978) 1.27
Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome. Hum Mol Genet (1995) 1.25
Mutations in the estrogen receptor ligand binding domain discriminate between hormone-dependent transactivation and transrepression. J Biol Chem (2000) 1.22
Testosterone control of nucleic acid content and proliferation of epithelium and stroma in rat seminal vesicles. Biochem J (1976) 1.22
Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists. Proc Natl Acad Sci U S A (1995) 1.19
Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer. Oncogene (2000) 1.18
A secretory protease inhibitor requires androgens for its expression in male sex accessory tissues but is expressed constitutively in pancreas. EMBO J (1987) 1.18
Effects of androgens on the complexity of poly(A) RNA from rat prostate. Cell (1977) 1.17
Hormonal regulation of protein synthesis in the rat epididymis. Characterization of androgen-dependent and testicular fluid-dependent proteins. Biochem J (1980) 1.16
The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1. J Biol Chem (2000) 1.15
Testosterone regulates the synthesis of major proteins in rat ventral prostate. Biochem J (1978) 1.14
Characterization of antibodies to androgen-dependent secretory proteins of the mouse dorsolateral prostate. Endocrinology (1990) 1.14
Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine. EMBO J (1997) 1.13
Prostatic steroid-binding protein. Isolation and characterization of C3 genes. J Biol Chem (1983) 1.12
Androgen-regulated expression of a cloned rat prostatic c3 gene transfected into mouse mammary tumor cells. Cell (1983) 1.12
A 22-amino-acid peptide restores DNA-binding activity to dimerization-defective mutants of the estrogen receptor. Mol Cell Biol (1990) 1.11
A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators. Proc Natl Acad Sci U S A (1997) 1.10
Early events in glucocorticoid action. Activation of the steroid receptor and its subsequent specific nuclear binding studied in a cell-free system. J Biol Chem (1973) 1.09
Effects of testosterone on messenger ribonucleic acid and protein synthesis in rat seminal vesicle. Biochem J (1978) 1.09
Cloning and characterization of androgen-dependent mRNA from rat ventral prostate. J Biol Chem (1980) 1.09
Nuclear receptors spring into action. Nat Struct Biol (1996) 1.08
Mechanism of estrogen receptor-dependent transcription in a cell-free system. Mol Cell Biol (1990) 1.07
Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology (1996) 1.06
General presence of glucocorticoid receptors in mammalian tissues. Endocrinology (1974) 1.05
Socioeconomic status, marital status and hip fracture risk: a population-based case-control study. Osteoporos Int (2000) 1.04
Blood gases and acid-base values of unanesthetized rats exposed to hypoxia. Am J Physiol (1967) 1.04
Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression. Oncogene (2007) 1.04
CAAT/enhancer binding protein is able to bind to ATF/CRE elements. Nucleic Acids Res (1991) 1.02
The polymorphic epithelial mucin: potential as an immunogen for a cancer vaccine. Cancer Immunol Immunother (1996) 1.02
The contribution made by a single somite to the vertebral column: experimental evidence in support of resegmentation using the chick-quail chimaera model. Development (1988) 1.02
Evidence for induced synthesis of an active transport factor for mandelate in Pseudomonas putida. Biochem J (1972) 1.01
Characterization of ligand-dependent phosphorylation of the estrogen receptor. Mol Endocrinol (1994) 1.00
Malignancy and chronic wounds: Marjolin's ulcer. J Burn Care Rehabil (1991) 1.00
Functional estrogen receptors in osteoblastic cells demonstrated by transfection with a reporter gene containing an estrogen response element. Mol Endocrinol (1991) 0.99
Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model. Br J Cancer (2009) 0.98
Morphogenesis in Myxococcus xanthus and Myxococcus virescens Myxobacterales. Arch Microbiol (1976) 0.98
1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene, an extremely potent modulator of mouse hepatic cytochrome P-450 gene expression. Biochem J (1993) 0.98
The prevalence of pain among the oldest old in Sweden. Pain (1996) 0.97
Crystal structure at 1.95 A resolution of the breast tumour-specific antibody SM3 complexed with its peptide epitope reveals novel hypervariable loop recognition. J Mol Biol (1998) 0.97
Characterization of domains obtained from a mollusc haemocyanin by limited proteolytic digestion. Biochem J (1979) 0.97
COUP-TF II homodimers are formed in preference to heterodimers with RXR alpha or TR beta in intact cells. Nucleic Acids Res (1995) 0.96
Regulation of prostatic steroid binding protein mRNAs by testosterone. Mol Cell Endocrinol (1985) 0.96
Interplay between estrogens, progestins, retinoic acid and AP-1 on a single regulatory site in the progesterone receptor gene. J Biol Chem (1994) 0.96
The androgenic regulation of abundant mRNA in rat ventral prostate. Eur J Biochem (1978) 0.96
Nuclear binding of glucocorticoid receptors: relations between cytosol binding, activation and the biological response. J Steroid Biochem (1980) 0.95
Mobility limitations in the Swedish population from 1968 to 1992: age, gender and social class differences. Aging (Milano) (2000) 0.94
Cross-talk between Stat5b and estrogen receptor-alpha and -beta in mammary epithelial cells. J Mol Endocrinol (2001) 0.94
Androgen-regulated expression of secretory protein synthesis in mouse ventral prostate. Mol Cell Endocrinol (1987) 0.93
The structure of porphyrins and haems in aqueous solution. Int J Biochem (1980) 0.93
Tissue-specific and hormonal regulation of the gene for rat prostatic steroid-binding protein in transgenic mice. Mol Cell Biol (1989) 0.93
Effect of androgen on the transcription of rat prostatic binding protein genes. Mol Cell Endocrinol (1982) 0.93
Analysis of the aromatase cytochrome P450 gene in human breast cancers. J Mol Endocrinol (1994) 0.93